⌕
GE HealthCare Technologies · GEHC · Nasdaq
Tenet 45 · Mixed
Compare
$81.84−1.35%At closeTenet 45 · Mixed
$81.84−1.12 (−1.35%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
$81.99+0.15 (+0.18%)
After hours: Nov 17, 2026, 7:27 PM ET

GE HealthCare Technologies (GEHC) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineSteady: revenue compounds ~4.1%/yr (FY21→FY25), net margin 10.1%; free cash flow runs at 70% of net income. Check the accrual gap.
The four lines that matter · FY21–FY25
Revenue ($B)▲4.8%
20.6
FY21→FY25CAGR +4.1%/yr
Net income ($B)▲4.6%
2.1
one-off year: see footnoteCAGR −2.4%/yr
Free cash flow ($B)▼2.9%
1.5
FY21→FY25CAGR +2.6%/yr
Diluted EPS▲4.8%
4.55
FY21→FY25CAGR −2.1%/yr
What the receipts whisper · what a headline number hides
Share count
+0.9%

454.0mn → 458.0mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.

Capex
$482.0M

+20.2% YoY in FY25 · 2.3% of revenue.

Returns vs FCF
18%

$0.3B returned vs $1.5B of FCF in FY25. Buybacks + dividends covered by cash flow.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($B)20.6Revenue−12.4COGS8.2Gross profit−1.3R&D−4.2SG&A2.8Op income−0.7Tax & other2.1Net income

10¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
503825130%sector median net margin ~3%FY21FY25

Over this window: gross 40.8% → 40.0%. Net margin 10.1% is more than double the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
21,637.020,625.019,672.019,552.018,341.017,585.0▲4.8%+4.1%
Cost of revenue
12,994.012,378.011,467.011,630.011,162.010,411.0▲7.9%+4.4%
Gross profit
8,642.08,248.08,205.07,922.07,179.07,174.0▲0.5%+3.5%
Research & development
1,310.01,260.01,311.01,205.01,026.0816.0▼3.9%+11.5%
Selling, general & admin
4,446.04,225.04,269.04,282.03,631.03,563.0▼1.0%+4.4%
Total operating expenses
5,756.05,485.05,580.05,487.04,657.04,379.0▼1.7%+5.8%
Operating incomefeeds ROC rank
2,886.02,763.02,625.02,435.02,522.02,795.0▲5.3%−0.3%
Other income, net
−116.05.0−44.0−74.0−10.080.0——
Pretax income
2,770.02,768.02,581.02,361.02,512.02,875.0▲7.2%−0.9%
Income tax
560.0614.0531.0743.0563.0600.0▲15.6%+0.6%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
2,151.02,084.01,993.01,568.01,916.02,293.0▲4.6%−2.4%
Per share
Diluted EPSbuyback-sensitive
4.734.554.343.034.224.95▲4.8%−2.1%
Diluted shares (mn)
453.00458.00459.00458.00454.00454.00▼0.2%+0.2%
Margins
Gross margin21st pct in Healthcare
39.9%40.0%41.7%40.5%39.1%40.8%▼1.7pp−0.8pp
Operating margin
13.3%13.4%13.3%12.5%13.8%15.9%▲0.1pp−2.5pp
Net margin68th pct in Healthcare
9.9%10.1%10.1%8.0%10.4%13.0%▼0.0pp−2.9pp
† TTM = trailing four quarters through 2026-09-30.FY23 effective tax rate was 31% vs a 22% norm for this window, likely a one-time item; see the filing.
CSV export is on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-04 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was GE HealthCare Technologies' revenue last fiscal year?

GE HealthCare Technologies reported revenue of $20.6B in fiscal 2025, up 4.8% from fiscal 2024.

What was GE HealthCare Technologies' net income?

GE HealthCare Technologies reported net income of $2.1B in fiscal 2025, a net margin of 10.1%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.